Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin Â± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial
The optimal regimen for adjuvant treatment has not been established in GC yet. We plan to compare TS-1, TS-1/oxaliplatin with or without RT in D2 resected gastric cancer.
Gastric Cancer
DRUG: TS-1, oxaliplatin
The primary endpoint of the study is disease-free survival (DFS)., 3-year
The optimal regimen for adjuvant treatment has not been established in GC yet. We plan to compare TS-1, TS-1/oxaliplatin with or without RT in D2 resected gastric cancer.